- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x GOL: GLYCEROL(Non-functional Binders)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.3: 19 residues within 4Å:- Chain A: T.75, I.76, T.77, R.82, N.96, A.308, H.309, G.310, T.311, V.312, T.313, R.314, H.315, S.326, T.327, N.328, D.375
- Ligands: QDC.4, QD8.5
16 PLIP interactions:16 interactions with chain A- Hydrogen bonds: A:T.75, A:T.77, A:T.77, A:R.82, A:R.82, A:N.96, A:A.308, A:G.310, A:T.311, A:V.312, A:T.313, A:N.328, A:N.328
- Water bridges: A:R.314
- Salt bridges: A:R.314, A:H.315
NDP.8: 23 residues within 4Å:- Chain A: D.253, K.260
- Chain B: K.72, A.74, T.75, I.76, T.77, R.82, N.96, L.288, G.289, E.306, A.307, A.308, H.309, G.310, T.311, T.313, R.314, N.328, D.375
- Ligands: QDC.10, QD8.11
18 PLIP interactions:18 interactions with chain B- Hydrogen bonds: B:K.72, B:T.75, B:T.77, B:T.77, B:R.82, B:R.82, B:N.96, B:H.309, B:G.310, B:G.310, B:T.311, B:T.313, B:T.313, B:T.313, B:R.314, B:N.328
- Salt bridges: B:R.314
- pi-Cation interactions: B:R.314
- 2 x QDC: (R)-3-butyl-2-oxopentanedioic acid(Non-covalent)
QDC.4: 14 residues within 4Å:- Chain A: T.77, S.94, N.96, G.97, R.100, R.109, Y.139, D.275
- Chain B: K.212, I.215, D.252
- Ligands: NDP.3, QD8.5, CA.7
9 PLIP interactions:7 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:Y.139, A:Y.139, B:I.215
- Hydrogen bonds: A:S.94, A:N.96, B:K.212
- Water bridges: A:T.77
- Salt bridges: A:R.100, A:R.109
QDC.10: 15 residues within 4Å:- Chain A: K.212, I.215, D.252
- Chain B: T.77, S.94, N.96, G.97, R.100, R.109, Y.139, D.275, A.308
- Ligands: CA.6, NDP.8, QD8.11
10 PLIP interactions:9 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:Y.139, B:Y.139
- Hydrogen bonds: B:T.77, B:S.94, B:N.96, B:A.308, A:K.212
- Water bridges: B:R.109
- Salt bridges: B:R.100, B:R.109
- 2 x QD8: (S)-3-butyl-2-oxopentanedioic acid(Non-covalent)
QD8.5: 13 residues within 4Å:- Chain A: T.77, S.94, N.96, G.97, R.100, R.109, Y.139, D.275
- Chain B: K.212, D.252
- Ligands: NDP.3, QDC.4, CA.7
8 PLIP interactions:7 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:Y.139, A:Y.139
- Hydrogen bonds: A:S.94, A:N.96, B:K.212
- Water bridges: A:T.77
- Salt bridges: A:R.100, A:R.109
QD8.11: 15 residues within 4Å:- Chain A: K.212, I.215, D.252
- Chain B: T.77, S.94, N.96, G.97, R.100, R.109, Y.139, D.275, A.308
- Ligands: CA.6, NDP.8, QDC.10
11 PLIP interactions:9 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:Y.139, B:Y.139, A:I.215
- Hydrogen bonds: B:T.77, B:S.94, B:N.96, B:A.308, A:K.212
- Water bridges: B:R.109
- Salt bridges: B:R.100, B:R.109
- 2 x CA: CALCIUM ION(Non-covalent)
CA.6: 5 residues within 4Å:- Chain A: D.252
- Chain B: D.275, D.279
- Ligands: QDC.10, QD8.11
4 PLIP interactions:1 interactions with chain A, 1 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: A:D.252, B:D.275, H2O.3, H2O.4
CA.7: 5 residues within 4Å:- Chain A: D.275, D.279
- Chain B: D.252
- Ligands: QDC.4, QD8.5
5 PLIP interactions:1 interactions with chain A, 1 interactions with chain B, 2 Ligand-Water interactions, 1 Ligand-Ligand interactions- Metal complexes: A:D.275, B:D.252, H2O.1, H2O.1, QD8.5
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, X. et al., Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2. J.Biol.Chem. (2023)
- Release Date
- 2022-11-02
- Peptides
- Isocitrate dehydrogenase [NADP] cytoplasmic: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x GOL: GLYCEROL(Non-functional Binders)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x QDC: (R)-3-butyl-2-oxopentanedioic acid(Non-covalent)
- 2 x QD8: (S)-3-butyl-2-oxopentanedioic acid(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, X. et al., Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2. J.Biol.Chem. (2023)
- Release Date
- 2022-11-02
- Peptides
- Isocitrate dehydrogenase [NADP] cytoplasmic: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B